Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $120.00. The company's market cap stands at 297.45B, with a P/E ratio of 16.52 and a dividend yield of 2.7%.
As of 2026-04-01, Merck(MRK) stock has fluctuated between $118.40 and $121.25. The current price stands at $120.00, placing the stock +1.4% above today's low and -1.0% off the high.
The Merck(MRK)'s current trading volume is 10.71M, compared to an average daily volume of 11.48M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $125.14 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $125.14 at its peak.
MRK News
Stocks Near A Buy Zone Dow Jones Drug Giant Merck, Costco Approach New Buy Points Licensing As the Dow Jones Industrial Average and other stock indexes traded h...
A study of analyst recommendations at the major brokerages shows that Merck & Co Inc (Symbol: MRK) is the #8 broker pick, on average, out of the 30 stocks makin...
Merck (NYSE:MRK) reported positive Phase 3 results for its oral PCSK9 inhibitor, enlicitide decanoate, showing marked LDL C reduction and a favorable safety pro...
Analyst ratings
63%
of 30 ratingsMore MRK News
Truist analyst Srikripa Devarakonda downgraded Terns Pharmaceuticals (TERN) to Hold from Buy with a price target of $53, down from $56, after the company agreed...
Merck (MRK) announced detailed results from CORALreef AddOn, an active comparator study designed to evaluate the efficacy and safety of enlicitide decanoate com...
Technology How Merck's New Cholesterol Buster Will 'Move The Needle' 'By Removing The Needle' Licensing Merck's (MRK) experimental cholesterol buster easily out...
(RTTNews) - Merck (MRK) announced detailed results from the Phase 2 CADENCE study, which evaluated the efficacy, safety, and tolerability of two doses (0.3 mg/k...
Merck (MRK) has drawn attention after recent share price moves, with the stock showing mixed short term performance while still reflecting longer term gains tha...
Helen Louise Collins, Chief Medical Officer of Enliven Therapeutics (ELVN 1.17%), reported the exercise of 40,000 stock options for Common Stock and immediate s...
Wondering if Merck at around US$119 per share still offers value, or if most of the upside is already reflected in the price? This article walks through the key...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.